These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29137258)

  • 1. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.
    Wu M; Guan J; Li C; Gunter S; Nusrat L; Ng S; Dhand K; Morshead C; Kim A; Das S
    Oncotarget; 2017 Oct; 8(47):82217-82230. PubMed ID: 29137258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
    Shi L; Fei X; Wang Z; You Y
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.
    Singer E; Judkins J; Salomonis N; Matlaf L; Soteropoulos P; McAllister S; Soroceanu L
    Cell Death Dis; 2015 Jan; 6(1):e1601. PubMed ID: 25590811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical WNT pathway inhibition reduces ATP synthesis rates in glioblastoma stem cells.
    Ouwens DM; Hewera M; Li G; Di W; Muhammad S; Hänggi D; Steiger HJ; Dumitru CA; Sandalcioglu E; Croner RS; Zhang W; Kakhlon O; Kahlert UD
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):35. PubMed ID: 35090340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation.
    Kierulf-Vieira KS; Sandberg CJ; Grieg Z; Günther CC; Langmoen IA; Vik-Mo EO
    Exp Cell Res; 2016 Jan; 340(1):53-61. PubMed ID: 26712519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to tumor necrosis factor-α mediated inflammation involving activation of prostaglandin E2 and Wnt signaling in nucleus pulposus cells.
    Hiyama A; Yokoyama K; Nukaga T; Sakai D; Mochida J
    J Orthop Res; 2015 Dec; 33(12):1756-68. PubMed ID: 26123748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
    Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
    Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma Stem Cells: Signaling, Microenvironment, and Therapy.
    Liebelt BD; Shingu T; Zhou X; Ren J; Shin SA; Hu J
    Stem Cells Int; 2016; 2016():7849890. PubMed ID: 26880988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.
    Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X
    Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
    Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
    J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.
    Zuccarini M; Giuliani P; Ziberi S; Carluccio M; Iorio PD; Caciagli F; Ciccarelli R
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29462960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid ceramidase and its inhibitors: a
    Doan NB; Alhajala H; Al-Gizawiy MM; Mueller WM; Rand SD; Connelly JM; Cochran EJ; Chitambar CR; Clark P; Kuo J; Schmainda KM; Mirza SP
    Oncotarget; 2017 Dec; 8(68):112662-112674. PubMed ID: 29348854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.